TotalMarketCap

UroGen Pharma

URGNNasdaq IsraelHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$1.261 B

$25.72 -10.53%

Close of 6 Nov 2026

As of 6 Nov 2026, UroGen Pharma (URGN) has a market capitalization of $1.26B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$109.8M

#2457 by revenue

Earnings

-$153.5M

Loss-making

Shares outstanding

49,047,823

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #131Opko HealthOPK$1.30B
  2. #132GH ResearchGHRS$1.26B
  3. #133UroGen PharmaURGN$1.26B
  4. #134Nektar TherapeuticsNKTR$1.24B
  5. #135OmerosOMER$1.24B

What if UroGen Pharma were worth as much as…

Open the what-if tool →

Gold $28.2T

$575,700.86

Per share 22,388× higher

Bitcoin $1.53T

$31,150.17

Per share 1,211× higher

Apple $5.02T

$102,263.10

Per share 3,977× higher

Or at a round number

$2.00B$5.00B$10.0B$20.0B

Where these numbers come from

Share counts and financials for UroGen Pharma are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.